Advertisement
UK markets close in 2 hours 22 minutes

  • FTSE 100

    8,158.10
    +36.86 (+0.45%)
     

  • FTSE 250

    20,026.44
    +99.85 (+0.50%)
     

  • AIM

    766.72
    +1.74 (+0.23%)
     

  • GBP/EUR

    1.1692
    +0.0008 (+0.07%)
     

  • GBP/USD

    1.2508
    -0.0016 (-0.13%)
     

  • Bitcoin GBP

    46,892.06
    +696.85 (+1.51%)
     

  • CMC Crypto 200

    1,268.99
    -1.75 (-0.14%)
     

  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • CRUDE OIL

    79.23
    +0.23 (+0.29%)
     

  • GOLD FUTURES

    2,306.20
    -4.80 (-0.21%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,207.13
    +444.10 (+2.50%)
     

  • DAX

    17,959.73
    +27.56 (+0.15%)
     

  • CAC 40

    7,932.79
    -52.14 (-0.65%)
     
Money:

Best UK mortgage deals of the week

The cheapest home loans available now

BUZZ-GlaxoSmithKline: gains as Pfizer bid talk resurfaces

Reuters - UK Focus

** GlaxoSmithKline (Other OTC: GLAXF - news) up 3.4 pct in decent volume as talk resurfaces in newspaper market reports that Pfizer might bid for the British drugmaker (£19-a-share cash offer), after failing to win AstraZeneca (NYSE: AZN - news) last year

** (Link:http://bit.ly/1hkxgyY) (Link:http://bit.ly/1Nc7x5V)

** Pfizer (NYSE: PFE - news) spokesman says company doesn't comment on market speculation and rumour

** Idea of a Pfizer move on GSK first mooted by Berenberg Bank last August, with Deutsche Bank (Xetra: 514000 - news) outlining merits of creating "PfizerKline" in research note in May

** Despite Pfizer's readiness to do deals, scepticism remains high given likely political resistance to takeover of Britain's biggest pharmaceutical company

ADVERTISEMENT

** GSK third-top riser on FTSE 100 & most actively traded stock on the index, with nearly all of its 90-day daily avg having gone through c.3 hours before the close

(RM (LSE: RM.L - news) : ben.hirschler.thomsonreuters.com@reuters.net)